Helix3 enables people to take control of their medical, genome and fitness data in a meaningful way. The platform integrates with various fitness devices and medical records systems to create a personal health profile for the user to securely manage and exchange their data. This creates a single source of truth to interact with the user doctor, lab, pharmacy, local gym, family member or employer.

Helix3 ICO began on October 15, 2018. The ICO token supply represents 40% of the total token supply, so there is a total of 355,200,000 HLX tokens available, for 0.08 USD each. The ICO funding target is 2,000,000 USD, the funding cap is 28,400,000 USD and is expected to end on January 15, 2019 or when the funding cap is reached. Any unsold/remaining tokens will be distributed to Helix3.

Team:

• Ray Belleville: Co-Founder - Chief Strategist.  
• Nick White: Co-Founder - CEO. 
• Jacob Smith: Chief Technology Officer. 

Token Reserve Split (60%): Unknown.